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Abstract. Ergothioneine is an emerging factor in cellular redox homeostasis in bacteria, fungi, plants 
and animals. Reports that ergothioneine biosynthesis may be important for the pathogenicity of 
bacteria and fungi raise the question as to how this pathway is regulated and whether the 
corresponding enzymes may be therapeutic targets. The first step in ergothioneine biosynthesis is 
catalyzed by the methyltransferase EgtD that converts histidine into N-α-trimethylhistidine. This 
report examines the kinetic, thermodynamic and structural basis for substrate, product and inhibitor 
binding by EgtD from Mycobacterium smegmatis. This study reveals an unprecedented substrate 
binding mechanism and a fine-tuned affinity landscape as determinants for product specificity and 
product inhibition. Both properties are evolved features that optimize the function of EgtD in the 
context of cellular ergothioneine production. Based on these findings we developed a series of simple 
histidine derivatives that inhibit methyltransferase activity at low micromolar concentrations. 
Crystal structures of inhibited complexes validate this structure- and mechanism-based design 
strategy.  
 
Keywords. Methyltransferase, inhibitor design, mechanism, oxidative stress 
Introduction 
 
Ergothioneine (EGT, Figure 1), the betaine of 2-mercaptohistidine, is a ubiquitous metabolite. Many 
bacteria1-5 and most fungi biosynthesize EGT.1, 6 Plants and animals absorb EGT from their 
environment through a dedicated EGT transporter protein.7, 8 Active procurement of EGT by such a 
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diverse array of organisms indicates the EGT may play a fundamental role in cellular life. This 
hypothesis is more than half a century old but is now being tested and debated with increasing 
effort.9-14 Despite this recent attention, precise mechanisms by which EGT protects prokaryotic and 
eukaryotic cells are still elusive.11, 13, 14 The unusual redox activity and metal binding properties of the 
mercaptoimidazole side chain15-18 could enable EGT to participate in a broad range of processes19 
including protection against reactive oxygen species,20 reduction of oxidized heme-proteins,21 or 
passivating redox-active transition metals.22, 23  
 
Cellular dependence on EGT has been demonstrated for several microbial organisms.24 Deletion  of 
EGT biosynthetic genes in Mycobacterium smegmatis, Mycobacterium tuberculosis, Streptomyces 
coelicolor, Neurospora crassa and Aspergillus fumigatus produced strains with reduced resistance 
against oxidative stress.25-31 In M. tuberculosis these deletions increased susceptibility to 
antimycobacterial drugs, and decreased viability in macrophages and in mice.30 These recent findings 
raise the possibility that EGT biosynthesis – a process that does not occur in human cells – may be a 
target for novel antiinfective therapeutics. The genetic studies also agree that mutating the gene for 
the S-adenosylmethionine (SAM) dependent methyltransferase EgtD induces complete EGT 
deficiency in bacteria and fungi. This dependence validates EgtD as a potential target for EGT 
biosynthesis inhibitors. 
 
EgtD initiates EGT biosynthesis by methylating histidine (HIS) to produce N-α-trimethylhistidine 
(TMH) via the intermediates N-α-monomethyl- (MMH) and N-α-dimethylhistidine (DMH).2, 32, 33 TMH 
is consumed by the oxygen- and iron-dependent sulfoxide synthase EgtB. This enzyme attaches the 
sulfur atom of γ-glutamylcysteine (γGC) to carbon 2 on the imidazole ring of TMH.34, 35 Subsequent 
steps catalyzed by the amidohydrolase EgtC and the β-lyase EgtE result in EGT (Figure 1).36, 37 Fungal 
homologs of EgtB utilize cysteine instead of γGC as sulfur donor, but the chemistry of this reaction is 
likely similar to that of mycobacterial enzymes.27, 38-40 Some cyanobacterial species recruited a 
homologous iron-dependent enzyme from a different pathway to act as an EgtB surrogate in EGT 
production.41 An even more surprising variation of this pathway occurs in anaerobic green sulfur 
bacteria. These organisms utilize a rhodanese-like enzyme (EanB) to attach sulfur to TMH in an 
oxygen-independent reaction.5 All these pathway variations include an EgtD-type methyltransferase, 
making this enzyme  the sole indispensable component of EGT production (Figure 1). 
 
Figure 1. Four biosynthetic pathways for ergothioneine (EGT) production in mycobacteria,2 fungi, 27, 38-40 cyanobacteria,41 and 
anaerobic green sulfur bacteria.5 
 
The growing recognition of EGT as a relevant factor in microbial metabolism and the key role of EgtD 
in EGT biosynthesis motivated us to examine the kinetic, thermodynamic and structural basis for 
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ligand recognition by EgtD from M. smegmatis. This analysis revealed i) that EgtD binds its substrate 
by a mechanism which is unprecedented among SAM-dependent methyltransferases, ii) that EgtD 
activity is subject to stringent feedback regulation and iii) and that the EgtD active site can adapt to 
methylate a primary, a secondary and a tertiary amine with increasing efficiency. These findings 
were used to develop and validate the first designs of specific EgtD inhibitors. 
 
Results and Discussion 
 
Substrate-binding order. EgtD consumes three SAM equivalents to methylate HIS to TMH in three 
consecutive two-substrate – two-product reactions with MMH and DMH as reaction intermediates.42 
In principle it is possible that trimethylation is processive, meaning that HIS only leaves the enzyme 
after all three methyl groups are installed. This model is unlikely. Assuming diffusion-limited 
substrate binding, and a dissociation constant of 4 uM for the EgtD:DMH complex, we find that 
unproductive dissociation of this complex is at least 103-fold faster than turnover to TMH.33  Hence, 
EgtD-catalyzed trimethylation is a distributive process. The efficiency of EgtD-catalyzed consumption 
of SAM is two-fold and three-fold less efficient when the methyl acceptor is HIS instead of  DMH or 
MMH,33 showing that the first methyl transfer is the rate limiting step of TMH production. Therefore, 
we concluded that the steady-state behavior of EgtD is dominated by the first methylation step.  
 
The order of substrate binding was elucidated by measuring the apparent Michaelis-Menten 
parameters kcat and KM for HIS and SAM as a function of both substrate concentrations (Figure S1).33 
EgtD-catalyzed consumption of SAM was monitored by an enzyme-coupled UV assay.43 The recorded 
data revealed that the apparent KM,SAM depends on [HIS], but that the apparent KM,HIS is largely 
independent of [SAM] (Figure 2). This behavior is diagnostic for an ordered sequential substrate 
binding mechanism, with HIS as the leading substrate.42  
 
 
Figure 2. Lineweaver–Burk plots of kinetic data used to examine the substrate binding mechanism of EgtD. Top: 
Primary and secondary plots with SAM as the variable substrate in presence of different concentrations of HIS. 
Bottom: Primary and secondary plots with HIS as the variable substrate in presence of different concentrations 
of SAM.  
 
An obligatory binding order is consistent with the structure of EgtD (Figure 3). The active site of this 
enzyme is located in a cleft between the SAM-binding Rossmann-fold domain and the HIS-binding 
domain. The first domain is conserved among class I methyltransferases,44, 45 but the second domain 
is exclusive to Methyltransf_33 enzyme family members, such as the Trp-, Tyr- and dimethylallyl-
tryptophan methyltransferases.33, 46  
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The crystal structure of EgtD in complex with DMH and SAH shows that the enzyme completely 
sequesters the methyl acceptor from bulk solvent (Figure 3). The only direct non-protein contact to 
DMH is provided by the sulfur atom of SAH. The only path for HIS in and out of this pocket leads 
through the SAM/SAH-binding site. Unless substrate binding is accompanied by large scale unfolding 
and refolding of the HIS-binding domain, the methyl-acceptor can reach its binding pocket only in the 
absence of SAM/SAH. Therefore substrate binding and product release must follow an ordered 
sequence.  
 
This methyl-acceptor first binding order distinguishes EgtD from all characterized natural product 
methyltransferases.47 Methyltransferases which methylate small substrates47 usually follow a SAM-
first or a random binding mechanism.  Some DNA-, RNA- or protein-methyltransferases may follow 
an apparent substrate-first binding mechanism.48 However, these enzymes often bind their 
macromolecular substrates through interactions outside the active side, which makes the 
comparison to enzymes with small substrates difficult. 
 
Figure 3: Structure of EgtD in complex with S-adenosyl homocysteine (SAH, green) and N-α-dimethylhistidine 
(DMH, orange)(PDB: 4PIO).5 The substrate-binding domain (blue) is formed by residues 1 – 60 and 196 – 286. 
The SAM-binding domain is conserved in most SAM-dependent methyltransferases. 
 
 
 
Product inhibition by TMH. EgtD is characterized by significant HIS-competitive inhibition by the 
product TMH. This behavior is also unusual for a SAM-dependent methyltransferase. To examine this 
trait of EgtD we recorded methyl-transfer activities in the presence of several TMH concentrations 
with either HIS or SAM as the substrate with variable concentration, while keeping the second 
substrate concentration constant. Plotting this data in form of Lineweaver–Burk plots showed that 
TMH behaves as a competitive inhibitor with respect to both substrates (Figure 4). The Ki for HIS-
competitive inhibition of EgtD by TMH was determined by measuring the apparent KM,HIS in the 
presence of 500 μM SAM and three different concentrations of TMH. From this data Ki was calculated 
using the equation Ki= KM[TMH]/(KM,app - KM)(Table 1, Figure S2).  
 
Table 1. Inhibition constants (Ki) for EgtD inhibitors[a] 
EgtD ligands Ki (μM) 
L-derivative 
Ki (μM) 
racemic 
TMH 39 ± 6 - 
1 - 8.5 ± 2.1 
2 21 ± 3 41 ± 6 
3 - 93 ± 11 
4 - 49 ± 14  
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5 - 5.4 ± 1.6 
6 - 72 ± 17 
7 - 25 ± 1 
8 2.6 ± 0.4 6.2 ± 1.5 
9 - 8.2 ± 2.4 
10 800 ± 200 - 
11 100 ± 40  - 
12 800 ± 200 - 
13 200 ± 80 - 
 
[a] HIS-competitive inhibition of EgtD was quantified by measuring the apparent KM,His at three different inhibitor 
concentrations in the presence of 500 μM SAM. Inhibition constants were determined using the equation Ki = KM[TMH]/(KM,app 
- KM) 
 
Table 2. Binding constants (KD) binary and ternary EgtD complexes [a] 
EgtD ligands KD  
(μM) 
∆G 
(kcal/mol) 
∆H 
(kcal/mol) 
Τ∆S 
(kcal/mol) 
HIS[b] 290 ± 14 -4.8 - 8.0  - 3.3 
HIS:SAH[b] 37 ± 1 -6.1 -10 -3.9 
MMH[b] 70 ± 30 -5.7 - 13  -7.5 
MMH:SAH[b] 14 ± 7 -6.6 -11 -4.5 
DMH[b] 4 ± 2 -7.4 -5.0 2.4 
DMH:SAH[b] 2 ± 1 -7.8 -27 -19 
TMH 26 ± 4 -6.3 -8.0 -1.6 
TMH:SAH 0.11 ± 0.01 -9.7 -9.2 0.2 
[a] Dissociation constants [KD] were determined by isothermal calorimetry titration at 25 °C. 
[b] Data from Ref.33 
 
 
 
The value of Ki for TMH corresponds well with the dissociation constant (Kd) of the EgtD:TMH 
complex as determined by isothermal titration calorimetry (Table 2, Figure S3). The affinity of EgtD 
for TMH increased by 240-fold in the presence of 7 mM SAH (Figure S3). However, because the 
reaction mixtures used for the kinetic measurements contained SAH nucleosidase and adenine 
deaminase, SAH cannot accumulate,43 and does not contribute to inhibition. Similarly, the SAH 
concentrations in living cells is also kept in the in the low micromolar range, suggesting that EgtD 
inhibition by SAH may not be significant in vivo.49 On the other hand, stress factors that lead to 
accumulation of SAH might indeed interfere with EGT production.  
 
 
Figure 4. Lineweaver–Burk plots of the data used to examine EgtD inhibition by TMH and 8. Top: Primary plots 
with HIS or SAM as the variable substrate in presence of different concentrations of TMH Bottom: Primary plots 
with HIS or SAM as the variable substrate in presence of different concentrations of 8.  
 
Comparison to related methyltransferases. Methyltransferases are commonly inhibited by the 
consumed methyl donor, S-adenosyl homocysteine (SAH), which acts as a SAM-competitive 
inhibitor.49 Inhibition by the methylated product is far less common among methyltransferases. 
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Therefore we wondered whether product inhibition by TMH is a specifically evolved feature of EgtD 
or whether this behavior is a mere consequence of the unusual substrate binding order or of the per-
methylation reaction. To address this question, two close EgtD homologs were examined. The first 
enzyme is the tyrosine betaine synthase (Ybs) from Aspergillus nidulans. Although Ybs shares only 28 
% sequence identity with EgtD,33 this fungal enzyme contains an almost identical set of active site 
residues. The only apparent differences between EgtD and Ybs map to the side chain binding pocket 
for the substrate. Hence, Ybs and EgtD should share all catalytic properties that are inescapable 
consequences of the protein architecture or the catalyzed reaction. 
 
Using the same kinetic assay as described above we determined that Ybs catalyzes tyrosine 
methylation with similar efficiency as EgtD catalyzed methylation of HIS (Table 3, Figure S4). In 
contrast to EgtD, Ybs is not inhibited by its final product N-α-trimethyltyrosine (TMY, Ki > 1 mM, 
Figure S5). The efficiencies at which the two enzymes catalyze the conversion of DMH or DMY to 
TMH or TMY, respectively, were also determined. EgtD-catalyzed methyl transfer is three-fold more 
efficient when the methyl acceptor is DMH instead of HIS.33 In contrast, Ybs-catalyzed methyl transfer 
is four-fold less efficient when the methyl acceptor is DMY instead of Tyr. As a consequence, EgtD and 
Ybs give rise to different product distributions when SAM is the limiting substrate. EgtD produces 
predominantly TMH, while Ybs produces predominantly DMY (Table 3).  
 
Similar observations were made with an engineered EgtD variant (EgtDE282A,M252V) that methylates 
tryptophan instead of HIS.33 The variant contains two mutations in the substrate-binding domain that 
accommodate an indole instead of an imidazole ring. The crystal structure of this enzyme in complex 
with tryptophan (Trp) revealed an otherwise unchanged active site geometry.33 EgtDE282A,M252V 
catalyzed methylation of Trp with an efficiency only six-fold lower than that of the wild type enzyme 
with HIS as substrate (Table 3, Figure S6). However, methylation of N-α-dimethyltryptophan (DMW) 
to N-α-trimethyltryptophan (TMW) is 20-fold less efficient than the corresponding transformation of 
DMH by EgtD. The reduced efficiency is due to a  reduced kcat, suggesting that suboptimal positioning 
of the non-native substrate in the mutated active site specifically affects methyl transfer to DMW. 
 
Based on the comparison of these three methyltransferases we conclude that efficient trimethylation 
and product inhibition as observed by EgtD are not inescapable consequences of the active site 
architecture, the catalyzed reaction type, or the substrate binding mechanism. More likely, the two 
behaviors rely on structural optimization of the EgtD active site and must have emerged by positive 
selection to serve a function. As will be discussed below, cooperative trimethylation and product 
inhibition may play important roles in quality control and regulation of EGT biosynthesis in 
Mycobacteria.  
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Table 3. Kinetic parameters of the aromatic amino acid betaine synthases a 
 
[a] Reaction conditions: 25 °C, Tris HCl 50 mM, pH 8, NaCl 50 mM, MnCl 200 µM, 500 μM SAM, SAH nucleosidase 
5 µM, adenine deaminase 10 µM 
[b] Data from Ref.33 
 
Structure of EgtD in complex with TMH. In order to mediate efficient trimethylation and to allow 
for product inhibition, EgtD must be able to bind to a primary, a secondary, a tertiary and a 
quaternary amine. How can this enzyme accommodate the changing hydrogen-bonding 
requirements of its ligand? To examine this question, we solved the crystal structure of EgtD in 
complex with TMH (Table S1 & S2). This structure superimposes with the EgtD:HIS 50 and the 
EgtD:DMH 33 complexes a mutual r.m.s.d. of 0.4 Å (entire chain). The three ligands HIS, DMH and TMH 
occupy essentially the same position and almost all atoms of the active site residues superimpose. 
The important exceptions are residues in direct contact with the α-amino moiety. These residues are 
Asn166 and Gly161. 
 
In the TMH complex two N-α-methyl groups make close contact with the backbone carbonyl of 
Gly161 (3.1 Å) and with the side chain carbonyl of Asn166 (3.2 Å). The carbonyls approach the N-α-
methyl groups in a (O-C-Nα) angle of 167° (Gly161) and 177° (Asn166) This geometry is suggestive 
of attractive interaction between the positively polarized methyl groups and the carbonyl functions. 
The third N-α-methyl group points toward the SAM-binding site. 
 
In the DMH complex, one N-α-methyl group makes the same interaction with the Gly161 carbonyl 
function (d = 3.0 Å) and the other N-α-methyl group points toward the SAM-binding site. Asn166 
moved 1.3 Å closer to the substrate to form a 2.7 Å hydrogen bond to the α-amino group of the 
ligand. In the HIS complex the ligand forms two rather loose hydrogen bonds to Asn166 (3.1 Å) and 
Gly161 (3.4 Å). In order to establish a hydrogen bond, the Gly161 carbonyl oxygen moved by 1.8 Å 
towards the α-amino group of HIS. This rearrangement is made possible by conformational changes 
of the backbone including residues 159 - 162.  
 
substrates enzyme kcat 
(s-1) 
KM 
(μM) 
kcat / KM 
(M-1s-1) 
MMH/DMH/TMH 
ratio (%) 
HIS[b] EgtD 5.8 x 10-1 110 5.3 x 103  
DMH[b] EgtD 4.3 x 10-1 32 1.7 x 104 <1/17/83 
Tyr[b] Ybs 1.1 x 10-1 21 5.2 x 103  
DMY Ybs 5.0 x 10-2 43 1.2 x 103 <1/60/40 
Trp[b] EgtDE282A,M252V 1.1 x 10-1 20 5.5 x 103  
DMW EgtDE282A,M252V 0.9 x 10-2 11 8.2 x 102 <1/95/5 
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The three structures show that EgtD solvates the N-α-amino moiety of its substrates and product by 
a highly polar pocket with adaptable size. Remarkably, HIS is by far the weakest binder, despite 
forming two classical hydrogen bonds  (Table 2).33 In the DMH complex the hydrogen bond to Gly161 
is lost, but the hydrogen bond to Asn166 becomes shorter and hence, stronger. As a consequence, 
DMH is a 100-fold stronger EgtD ligand (KD = 4 μM) than HIS. Surprisingly, TMH is still a 
comparatively strong ligand (Ki = 40 μM) even though both hydrogen bonds are lost. It is possible 
that the close interaction between two N-α-methyl groups and the carbonyls from Gly161 and 
Asn166 are attractive and partially compensate for the lack of hydrogen bonding.  
 
Figure 5. Crystal structures of EgtD in complex A) HIS (PDB entry 4UY7, 50); B) DMH (PDB entry 4PIN,33); C) TMH; D) 8; E) 2; 
F) 3 . Unbiased m|Fobs|-D|Fcalc| electron density (σ-level = 2) of the compounds is shown in green. 
 
Catalytic cycle. The structure of the EgtD:TMH complex also illustrates why TMH is necessarily a 
competitive inhibitor with respect to both HIS and SAM. A model of EgtD in complex with SAM and 
TMH indicates that the third N-α-methyl groups of TMH and the sulfonium methyl group of SAM 
would clash (Figure S7). Hence, binding to the two ligands is mutually exclusive. In the conformation 
of DMH observed in the EgtD:DMH complex the same steric clash would prevent binding of SAM. In 
order to form the ternary complex DMH (a, Figure 6) must first adopt an alternative conformation in 
which the two N-α-methyl groups point towards Asn166 and Gly161 (b). This conformer can accept 
SAM (c) to form the reactive complex that decays via S- to N-methyl transfer to form the product 
complex (d). Based on this mechanistic model we hypothesized that DMH analogs that make the 
same interactions in the active site but cannot undergo the same conformational change could be 
potent EgtD inhibitors.  
 
Figure 6. Mechanism of EgtD-catalyzed methylation of DMH. Residues Asn166 and Gly161 are shown in gray. 
 
Strategies for inhibitor design. To test this idea we synthesized histidine derivatives with cyclic 
tertiary amines in place of the N-α-dimethyl amino moiety of DMH (Figure 5, see supporting 
information). The syntheses and characterization of compounds depicted in Figure 7 are described in 
the supporting information. The inhibitory activities were measured using the same assay as 
described above. Consistent with the design strategy compounds 1, 2, and 3 were not methylated by 
EgtD, but instead inhibit EgtD-catalyzed methylation of HIS (Figure S8 & S9, Table 1). In the presence 
of 0.5 mM SAM, inhibition by 1, 2, and 3 is characterized by inhibition constants (Ki) of 9, 40 and 90 
μM respectively (Table 1). Compounds 1, 2 and 3 were synthesized in racemic form. Given that EgtD 
only interacts with L-amino acids, it is fair to assume that only the L-isomers of the inhibitors would 
bind (Figure S10). This assumption is corroborated by the finding that the pure L-form of 2 inhibits 
EgtD  with a two-fold lower KI than measured for the racemic mixture (Table 1).  
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To examine the binding mode of these inhibitors, we determined the crystal structures of EgtD in 
complex with 2 and with 3 (Figure 5). Both structures show that the tertiary amines of 2 and 3 form 
the same hydrogen bond to Asn166 (2.9 and 3.0 Å) as seen in the EgtD:DMH complex (Figure 5). The 
electron density around ligands clearly shows that EgtD binds only the L-isomer of 2 and 3. One of 
the N-α-methylene carbons of 2 and 3 stacks against the carbonyl group of Gly161 (3.2 and 3.1 Å) 
and the rest of the pyrrolidino- and morpholino-rings block the space where the methyl group of 
SAM would approach the methyl acceptor. Both rings push the side chain of Thr163 which is pushed 
by 0.5 Å away from its position in the EgtD:TMH and EgtD:DMH structures. This steric stress also 
provides an explanation for why the size of the cyclic substituents in 1, 2 and 3 correlates inversely 
with their inhibitory activity (Table 1). 
 
 
 
Figure 7. Structure of tested EgtD inhibitors. 
 
Avoiding competition with SAM. As an alternative design strategy we examined inhibitors that only 
compete with HIS, but do not compete with SAM. Such compounds could form inhibited complexes 
with EgtD that are not destabilized by the generally high cellular concentration of SAM. To test this 
idea we synthesized racemic histidine derivatives with a proton (4), a methyl group (5), a hydroxyl 
group (6), fluoride (7), chloride (8) or bromide (9) in place of the α-amine group. In kinetic assays 
these compounds, except for 5, proved stronger HIS-competitive inhibitors than TMH (Table 1). The 
inhibition constant of the L-form of 8 was again two-fold lower than that of the racemic form, 
indicating that the active site selectively binds one isomer. Determination of the inhibition 
mechanism of chlorohistidine (8, Figure 4) revealed HIS-competitive and SAM-uncompetitive 
inhibition, suggesting that the EgtD:8 complex can still bind SAM. 
 
The crystal structure of EgtD in complex with 8 confirms that this ligand occupies the same active 
site position as all other co-crystallized histidine derivatives (Figure 5). Unlike the α-amine 
substituents in HIS, DMH, TMH, 2 and 3 the chloride substituent makes no direct contact with any 
protein residue. Solvation of the carboxylate and the imidazole ring by the active site apparently 
provides enough attractive interaction to induce strong inhibitory activity of the methyl- (5), chloro- 
(8) and bromo-substituted derivatives (9). The lower affinities of compounds 4, 6 and 7 are most 
likely due to stronger solvation of the free ligand by water. The relatively poor affinity of EgtD for 6 
mirrors the low affinity for HIS and corroborates the notion that the residues Gly161 and Asn166 are 
not particularly well positioned to engage in hydrogen bonding.  
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Bisubstrate inhibitors. A more common strategy to design inhibitors for methyltransferases targets 
the SAM-binding pocket. One successful way to increase the specificity towards one particular type of 
methyltransferase is to integrate structural motifs from SAM with those of the specific methyl 
acceptor into a single bisubstrate inhibitor.51-56 To explore this approach for the design of EgtD 
inhibitors we synthesized four histidine derivatives (10 – 13) that are N-substituted to mimic the 
methionyl moiety of SAM. All four compounds displayed weak inhibitory activity (Table 1, Figure 
S11). One explanation could be that that the amino acid substituents are not recognized by the 
methionyl-binding site in EgtD. Indeed, reinspection of EgtD in complex with DMH and SAH showed 
the possibility that the chosen methionyl mimics may be too short to bridge the histidine binding site 
and the methionyl-binding site. It is also possible that the compounds do bind as intended, but that 
recognition of the methionyl-moiety does not produce enough attractive interaction to outweigh 
competition with SAM and HIS. The observation that the additional N-α-methyl group on compounds 
11 and 13 increase the affinity by four to eight-fold provides further evidence that tertiary amines 
bind more strongly to EgtD than secondary amines.  
 
Feedback inhibition. EgtD catalyzes the first step in EGT biosynthesis (Figure 1). This reaction 
converts the primary metabolites HIS and SAM to TMH as a substrate for the subsequent enzyme 
EgtB. Methyltransferases are very common contributors to biosynthetic pathways in natural product 
biosynthesis.57 However, a cursory inspection of all methyltransferase entries in the Braunschweig 
Enzyme Database (BRENDA) shows that SAM-dependent methyl transfers rarely occur as first 
biosynthetic steps.58 For example, alkaloids or phenylpropanoids usually receive methyl groups at 
later biosynthetic stages.59-62  
 
The unique role of EgtD as the gateway to EGT production raises the specific problem of regulation. 
Two studies on a gliotoxin deficient strain of A. fumigatus, and a mycothiol-deficient strain of M. 
smegmatis revealed that these deficiencies are compensated by EGT overproduction. 63, 64 The 
mechanism by which ETG productivity is coupled to seemingly unrelated biosynthetic activity is not 
known. However, the two studies provide first indications that EGT production may be regulated.  
 
Because methyl transfer from SAM to His is essentially irreversible, and because both substrates are 
abundant metabolites, regulation of EgtD activity is essential, either by transcriptional control, by 
reversible inhibition or by destruction of the enzyme. One regulatory mechanism has been proposed 
based on the finding that EgtD from Mycobacterium tuberculosis may be a substrate of the protein 
kinase PknD.31 According to this model the kinase phosphorylates a key active site residue of EgtD 
(Thr213) to block activity.  
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The observation that EgtD is subject to significant product inhibition highlights an alternative mode 
of regulation. Most SAM-dependent methyltransferases are inhibited by the side product S-adenosyl 
homocysteine (SAH). Therefore, methyltransferase activities are often modulated by the cellular 
concentration of SAH or the ratio of SAH/SAM.49 Inhibition by the methylated product is far less 
common.65-70 The caffeoyl-coenzyme A 3-O-methyltransferase from Petroselinum crispum (Parsley) 
provides a rare exception. This enzyme is inhibited by its product feruloyl-CoA (Ki, feruloyl-CoA = 11 μM) 
which allows strict regulation of the steady-state product concentration.70 
 
By analogy, we hypothesize that product inhibition of EgtD may also have physiological relevance. 
Incidentally, the value of the associated inhibition constant (Ki,TMH = 40 μM, Table 1) lies in the same 
range as the KM for TMH (KM,TMH = 43 μM) of the next enzyme in the pathway, EgtB (Figure 1).34 These 
parameters ensure that TMH cannot accumulate to high concentrations even if EgtB activity 
decreases, for example due to limiting supply of the co-substrates γGC and O2. Consequently, the 
cellular supply of TMH is adjusted to the rate of EGT production. In addition, the stabilizing effect of 
SAH on the EgtD:TMH complex raises the possibility that EGT biosynthesis is also regulated by the 
cellular concentration of SAH. The underlying prediction that product inhibition of EgtD is a 
specifically evolved trait is corroborated by the finding that the homologous tyrosine betaine 
synthase Ybs is not inhibited by product despite significant active site similarity to EgtD.  
 
Proofreading. In addition to making the first intermediate in EGT biosynthesis, EgtD also serves as a 
quality control element of this pathway. Although EGT has been identified from a large range of 
sources,1, 4, 5, 23 there are no isolation reports of EGT derivatives that lack one, two or all N-α-methyl 
groups. For reasons that are not exactly clear the betaine moiety of EGT is important for 
physiological function. Subsequent enzymes in the EGT pathway are unable to proofread the 
methylation state of their substrates.2, 36, 37 For example, EgtB from M. smegmatis turns over DMH and 
TMH with almost the same efficiency.2 EgtC and EgtE are unlikely to prevent alternative products 
because the reaction catalyzed by EgtB is irreversible. Hence, the only mechanism to prevent the 
formation of unwanted EGT derivatives is to limit the cellular concentration of DMH. Limiting this 
concentration is an important role of EgtD. As shown in Table 2 EgtD binds HIS, MMH and DMH with 
increasing affinity. As a result, each added methyl group on the methyl acceptor increases the 
probability of further methylation. The three methyl groups are transferred in a cooperative process 
that avoids the accumulation of MMH or DMH.33 By contrast, the catalytic efficiency of the 
homologous enzymes Ybs and EgtDE282A,M252V drops significantly after the first two methyl transfers 
to Tyr ad Trp, respectively (Table 3). Comparisons of the EgtD structure with the homology model of 
Ybs, and the crystal structure of EgtDE282A,M252V do not reveal clear structural explanations for these 
different activities. One possibility is that transfer of the last methyl group is particularly sensitive to 
precise positioning of the N-α-dimethylated amino acid in the active site. Therefore, it is possible to 
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conclude that the ability of EgtD to catalyze cooperative trimethylation is also an essential and 
specifically evolved feature.  
 
Mechanistic implications. Finally, we would like to summarize what can be learned about the 
catalytic mechanism and about inhibitor design from the ligand binding preferences of EgtD. EgtD 
can form up to thirteen binary and ternary complexes with its six native ligands HIS, MMH, DMH, 
TMH, SAM and SAH (Figure 8). Among these, EgtD:DMH and EgtD:TMH:SAH are the strongest binary 
and ternary complexes (Table 2). The interaction between the amide side chain of Asn166 and the α-
amino function of DMH shows that the α-amino function of the methyl acceptor is protonated in the 
binary complex (Figure 5). Apparently, the active site stabilizes a cationic moiety in this position. 
Unreactive histidine derivatives with neutral substituents (5, 8 and 9) form strong complexes with 
EgtD and SAM, suggesting that in the ternary complex the sulfonium moiety of SAM fully satisfies the 
requirement for a cationic charge in the active site. Consequently, the methyl acceptors HIS, MMH 
and DMH must lose a proton before or concomitant to SAM binding. Also, in order to make room for 
the second substrate, deprotonation must be accompanied by inversion of the α-amine. For example, 
DMH must turn the two N-α-methyl groups towards Gly161 and Asn166 in order to juxtapose the 
nucleophilic lone pair with the sulfonium methyl group of SAM (Figure 6). Each methyl transfer from 
HIS to TMH makes the ligand larger. The structures of EgtD in complex with HIS, DMH and TMH show 
how the active site undergoes stepwise expansion by repositioning of Gly161 and Asn166 to 
accommodate the growing size of the ligand.  
 
To support efficient trimethylation the energy landscape of this expansion must be adjusted to 
increase the affinity for the methyl acceptor with each additional N-α-methyl group. As the 
thermodynamic binding data shows, EgtD follows exactly this expected behavior. A plot of the 
complex stabilities (∆Gbinding) of EgtD with SAH and HIS, DMH or TMH shows that each additional 
methyl group on the methyl acceptor increases the complex stability by 1.2 kcal/mol (Figure 8, Table 
2). A similar trend is apparent in the absence of SAH. Notably, the EgtD:TMH complex deviates from 
this trend. It seems possible that the stability of the EgtD:TMH complex is purposefully decreased to 
avoid  inhibition by sub-micromolar concentrations of TMH.  
 
A glance at the enthalpic and entropic contributions to the stability of the six complexes cautions that 
a purely structural interpretation of the binding data may be misleading (Table 2). For example, 
formation of the EgtD:DMH:SAH complex liberates more heat than formation of the EgtD:TMH:SAH 
complex. However, because the latter suffers almost no entropic penalty, the TMH complex is 20-fold 
more stable. The enthalpic term indicates that formation of a hydrogen bond to Asn166 and stacking 
one N-α-methyl group towards Gly161 in the EgtD:DMH:SAH complex amounts to more attraction 
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than the two N-α-methyl interactions with Gly161 and Asn166 in the EgtD:TMH:SAH complex. The 
basis for the large entropic difference is more difficult to localize. It is also interesting to note that 
conversion of the EgtD:HIS:SAH complex to the EgtD:TMH:SAH complex is accompanied by 300-fold 
stabilization, which is entirely due to entropic contributions. The same trend applies to the binary 
complexes in the absence of SAH. This result indicates that the two N-α-methyl interactions with 
Gly161 and Asn166 can at least partially compensate for the loss of the two hydrogen bonds in the 
EgtD:HIS:SAH complex. One interpretation of this result is that the two N-α-methyl interactions with 
protein carbonyl groups are at least weekly attractive.  
 
Figure 8. Top: Complete reaction scheme of EgtD catalyzed trimethylation of HIS. EgtD can combine with its six native ligands 
to 13 binary and ternary complexes. Bottom: the stability of EgtD complexes as determined by ITC (Table 2).  
 
Conclusion. This report describes the unusual substrate binding mechanism of the SAM-dependent 
methyltransferase EgtD. Unlike most methyltransferases, this enzyme follows an obligatory 
sequential binding mechanism with the methyl acceptor as the leading substrate. Secondly, this 
enzyme can regulate EGT production by way of product inhibition. Third, the enzyme ensures 
efficient permethylation of its substrate and suppresses the accumulation of mono- and dimethylated 
intermediates. Product inhibition and efficient permethylation are the result of specific evolutionary 
optimization. These findings were exploited to design three types of substrate competitive EgtD 
inhibitors. The most efficient inhibitors (5 & 8) are very simple histidine derivatives that provide 
promising leads for further development EGT biosynthesis inhibitors. 
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Four biosynthetic pathways for ergothioneine (EGT) production in Mycobacteria, fungi, cyanobacteria, and 
anaerobic green sulfur bacteria.  
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Lineweaver–Burk plots of the data used to examine the substrate binding mechanism of EgtD. Top: Primary 
and secondary plots with SAM as the variable substrate in presence of different concentrations of HIS. 
Bottom: Primary and secondary plots with HIS as the variable substrate in presence of different 
concentrations of SAM.  
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Structure of EgtD in complex with S-adenosyl homocysteine (SAH, green) and Nα-dimethylhistidine (DMH, 
orange)(PDB: 4PIO).5 The substrate-binding domain (blue) is formed by residues 1 – 60 and 196 – 286. The 
SAM-binding domain is conserved in most SAM-dependent methyltransferases.  
 
332x219mm (300 x 300 DPI)  
 
 
Page 19 of 25
ACS Paragon Plus Environment
ACS Chemical Biology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
  
 
 
Lineweaver–Burk plots of the data used to examine EgtD inhibition by TMH and 8. Top: Primary plots with 
HIS or SAM as the variable substrate in presence of different concentrations of TMH Bottom: Primary plots 
with HIS or SAM as the variable substrate in presence of different concentrations of 8.  
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Crystal structures of EgtD in complex A) HIS (PDB entry 4UY7, 50); B) DMH (PDB entry 4PIN); C) TMH; D) 
8; E) 2; F) 3 . Unbiased m|Fobs|-D|Fcalc| electron density (σ-level = 2) of the compounds is shown in 
green.  
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Mechanism of EgtD-catalyzed methylation of DMH. Residues Asn166 and Gly161 are shown in gray  
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Structure of tested EgtD inhibitors.  
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Top: Complete reaction scheme of EgtD catalyzed trimethylation of HIS. EgtD can combine with its six 
native ligands to 13 binary and ternary complexes. Bottom: the stability of EgtD complexes as determined 
by ITC (Table 2).  
 
80x75mm (300 x 300 DPI)  
 
 
Page 24 of 25
ACS Paragon Plus Environment
ACS Chemical Biology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
  
 
 
 
 
21x8mm (300 x 300 DPI)  
 
 
Page 25 of 25
ACS Paragon Plus Environment
ACS Chemical Biology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
